TARGET PharmaSolutions Launches Real-World Observational Study


Applied Clinical Trials

TARGET PharmaSolutions, Inc., a company focused on real-world evidence, launched its latest large-scale observational study, TARGET-DERM. The study will deliver real-world evidence for several immune-mediated inflammatory skin conditions (IMISCs), initially focusing on patients with atopic dermatitis (AD/eczema). and vitiligo (loss of skin pigment). 

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.